![SoMe4GynOnc Profile](https://pbs.twimg.com/profile_images/1157119268535713792/ZmXbNQ-X_x96.jpg)
SoMe4GynOnc
@GynMe4
Followers
2K
Following
2K
Statuses
2K
Social media platform promoting the goal of curing Gynecologic Cancer globally
Joined July 2019
RT @GreggNelsonERAS: Have you registered yet for @SGO_org 2025 Annual Meeting in #Seattle ?? I can’t wait for the science 🧬 🔪 🏥 but also th…
0
4
0
RT @GreggNelsonERAS: Cracking the Code: Surgical 🔪 🔐Coding in Gynecologic Oncology #SGO2025 #Masterclass🚨Register today!! @SGO_org
https://…
0
3
0
RT @gynoncjnls: Novel MXI1-NUTM2B fusion detected in undifferentiated ovarian cancer @SGO_org @ISGynP @ESGO_society @IGCSociety @OncoAlert…
0
3
0
RT @GreggNelsonERAS: More than Additive: Multiplying our Impact 💥🥊 in Endometrial Cancer Care #SGO2025 #MasterClass 🚨Register today! https:…
0
4
0
RT @gynoncjnls: Incorporating immune checkpoint inhibitors in epithelial ovarian cancer @SGO_org @IGCSociety @ESGO_society @OncoAlert https…
0
5
0
RT @GreggNelsonERAS: Was so great to be able to meet with #GynOnc friends and colleagues at the #WinterSGO @WhistlerBlckcmb welcome recepti…
0
2
0
RT @gynoncjnls: Value of magnetic resonance imaging in predicting vesicovaginal fistula in cervical cancer with bladder invasion treated wi…
0
10
0
RT @GreggNelsonERAS: Pro Tips for a Thriving Practice and Business in Gynecologic Oncology #SGO2025 #Masterclass @SGO_org 🚨 Register today!…
0
4
0
RT @gynoncjnls: Pseudo-Meigs’ syndrome in mucinous ovarian carcinoma @SGO_org @IGCSociety @ESGO_society @ISGynP @ASCO @OncoAlert
https://t.…
0
5
0
RT @GreggNelsonERAS: High stakes communication around complex surgical 🔪 decision-making #SGO2025 #Masterclass @SGO_org 🚨Register today!! h…
0
6
0
RT @nicoleflemingmd: Early-bird registration for @SGO_org Annual meeting is open until Jan 31st! Check out the fantastic program and master…
0
8
0
RT @GreggNelsonERAS: Check out the #SGO2025 @SGO_org #Masterclasses “Cracking the code” 🧮 “Gyn Onc is a pain in the neck” 😣 “Complex surgic…
0
3
0
RT @gynoncjnls: PD-L1-Expression in primary and recurrent vulvar squamous cell cancer @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert h…
0
6
0
RT @amandanfader: The @SGO_org Winter Meeting is the premier oncology winter/ski conference, & in the gorgeous backdrop of @WhistlerBlckcm…
0
9
0
RT @GreggNelsonERAS: Please register for the #SGO2025 Annual Meeting in #Seattle 👏 Will be so awesome! 🤩 #MultiplyYourImpact @SGO_org https…
0
5
0
RT @gynoncjnls: Provider👩⚕️ perspectives on caring for patients with limited English proficiency-a 🇺🇸 🇨🇦 survey 📋 of @SGO_org @ASCO @OncoA…
0
3
0
RT @gynoncjnls: Cervical stromal invasion and molecular characterization in stage II-IV endometrial cancers @SGO_org @IGCSociety @ESGO_soci…
0
5
0
RT @gynoncjnls: Added prognostic value of sentinel lymph node mapping in endometrial cancer to molecular subgroups @SGO_org @IGCSociety @ES…
0
4
0
RT @gynoncjnls: Digital cervicography using mobile phones📱with real-time consultation (DCRC) to improve performance of Visual Inspection wi…
0
7
0
RT @gynoncjnls: Cost-effectiveness💲of dostarlimab plus carboplatin-paclitaxel 💉 for primary advanced or recurrent endometrial cancer from a…
0
6
0